Cited by 142COVID-19 Clinical Research StudiesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisTransplantation: Methods and Outcomes

The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index, and 1 are not checked yet.

Increased odds of death for patients with interstitial lung disease and covid-19: a case-control study

Open access

Esposito, Anthony J., Menon, Aravind A., Ghosh, Auyon J., Putman, Rachel K., Fredenburgh, Laura E., El-Chemaly, Souheil Y., Goldberg, Hilary J., Baron, Rebecca M., Hunninghake, Gary M., Doyle, Tracy J.·2020·American Journal of Respiratory and Critical Care Medicine

DOI 10.1164/rccm.202006-2441lePMC PMC7737588

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1164/rccm.202006-2441le

Cites

10 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, march 1-30, 2020
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J. C., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,273
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
Fu, L., Wang, B., Yuan, T., Chen, X., Ao, Y., Fitzpatrick, T., Li, P., Zhou, Y., Lin, Y., Duan, Q., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.041 · Cited by 1,141
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis
Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S., Almehmadi, M., Alqahtani, A., Quaderi, S. A., Mandal, S., & Hurst, J. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233147 · Cited by 897
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
Li, H., Chen, C., Hu, F., Wang, J., Zhao, Q., Gale, R. P., & Liang, Y. (2020) · Leukemia · doi:10.1038/s41375-020-0848-3 · Cited by 262
The Role of Infection in Interstitial Lung Diseases
Azadeh, N., Limper, A. H., Carmona, E. M., & Ryu, J. H. (2017) · Chest · doi:10.1016/j.chest.2017.03.033 · Cited by 115

Show all 9 references

Sorted by citations

Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Azkur, A. K., Azkur, D., Gan, H. K., Sun, Y., Fu, W., Li, W., et al. (2020) · Allergy · doi:10.1111/all.14657 · Cited by 1,453
Tuning immunity through tissue mechanotransduction
Du, H., Bartleson, J. M., Butenko, S., Alonso, V., Liu, W. F., Winer, D. A., & Butte, M. J. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00761-w · Cited by 451
Idiopathic pulmonary fibrosis: state of the art for 2023
Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G. (2023) · European Respiratory Journal · doi:10.1183/13993003.00957-2022 · Cited by 359
The costs and benefits of senotherapeutics for human health
Raffaele, M., & Vinciguerra, M. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00300-7 · Cited by 140
Interstitial lung disease increases susceptibility to and severity of COVID-19
Lee, H. J., Choi, H., Yang, B., Lee, S.-K., Park, T. S., Park, D. W., Moon, J., Kim, T., Sohn, J. W., Yoon, H. J., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04125-2020 · Cited by 115
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Zsichla, L., & Müller, V. (2023) · Viruses · doi:10.3390/v15010175 · Cited by 121
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
Fadista, J., Kraven, L. M., Karjalainen, J. M., Andrews, S. J., Geller, F., Initiative, T. C.-1. H. G., Baillie, J. K., Wain, L. V., Jenkins, G. R., & Feenstra, B. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103277 · Cited by 91
The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19
Machnicki, S. C., Patel, D., Singh, A. K., Talwar, A., Mina, B. A., Oks, M., Makkar, P., Naidich, D. P., Mehta, A. C., Hill, N. S., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.04.004 · Cited by 91
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases
Chiner‐Vives, E., Cordovilla, R., de la Rosa, D., Clemente, M. M. G., Alonso, J. L. I., Otero, R., de Llano, L. P., Sellares-Torres, J., & de Granda‐Orive, J. I. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.03.011 · Cited by 80
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease
Gallay, L., Uzunhan, Y., Borie, R., Lazor, R., Rigaud, P., Marchand-Adam, S., Hirschi, S., Israël‐Biet, D., Valentin, V., & Cottin, V. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2638le · Cited by 74
Pulmonary function and COVID-19
Thomas, M., Price, O. J., & Hull, J. H. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2021.03.005 · Cited by 74
Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis
Liu, C., Lee, J., Ta, C., Soroush, A., Rogers, J. R., Kim, J. H., Natarajan, K., Zucker, J. E., Perl, Y., & Weng, C. (2022) · JMIR Public Health and Surveillance · doi:10.2196/35311 · Cited by 69
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Arish, M., Qian, W. G., Narasimhan, H., & Sun, J. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28122 · Cited by 55
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
Mackintosh, J. A., Keir, G. J., Troy, L. K., Holland, A. E., Grainge, C., Chambers, D. C., Sandford, D., Jo, H. E., Glaspole, I., WILSHER, M. L., et al. (2024) · Respirology · doi:10.1111/resp.14656 · Cited by 54
Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
Patrucco, F., Solidoro, P., Gavelli, F., Apostolo, D., & Bellan, M. (2023) · Microorganisms · doi:10.3390/microorganisms11040895 · Cited by 55
Lung fibrosis: Post-COVID-19 complications and evidences
Hirawat, R., Jain, N., Saifi, M. A., Rachamalla, M., & Godugu, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109418 · Cited by 54
Update in Interstitial Lung Disease 2020
Podolanczuk, A. J., Wong, A. W., Saito, S., Lasky, J. A., Ryerson, C. J., & Eickelberg, O. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202103-0559up · Cited by 55
Active Smokers Are at Higher Risk of COVID-19 Death: A Systematic Review and Meta-analysis
Patanavanich, R., Siripoon, T., Amponnavarat, S., & Glantz, S. A. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac085 · Cited by 51
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
Figueroa‐Parra, G., Gilbert, E., Valenzuela-Almada, M. O., Vallejo, S., Neville, M. R., Patel, N. J., Cook, C., Fu, X., Hagi, R., McDermott, G. C., et al. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00227-2 · Cited by 50
A Causal Atlas on Comorbidities in Idiopathic Pulmonary Fibrosis
Zhu, J., Zhou, D., Wang, J., Yang, Y., Chen, D., He, F., & Li, Y. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.02.038 · Cited by 48
Interstitial lung disease before and after COVID-19: a double threat?
Valenzuela, C., WATERER, G. W., & Raghu, G. (2021) · European Respiratory Journal · doi:10.1183/13993003.01956-2021 · Cited by 48
COVID‐19 patients with documented alcohol use disorder or alcohol‐related complications are more likely to be hospitalized and have higher all‐cause mortality
Bailey, K. L., Sayles, H. R., Campbell, J. R., Khalid, N., Anglim, M., Ponce, J., Wyatt, T. A., McClay, J. C., Burnham, E. L., Anzalone, A. J., et al. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14838 · Cited by 46
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity
Bui, L. T., Winters, N. I., Chung, M.-I., Joseph, C., Gutierrez, A. J., Habermann, A. C., Adams, T. S., Schupp, J. C., Poli, S., Peter, L. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24467-0 · Cited by 45
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
Sinha, S., Castillo, V., Espinoza, C. R., Tindle, C., Fonseca, A. G., Dan, J. M., Katkar, G. D., Das, S., Sahoo, D., & Ghosh, P. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104185 · Cited by 46
Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
Ntatsoulis, K., Karampitsakos, Τ., Tsitoura, E., Stylianaki, E.-A., Matralis, A. N., Tzouvelekis, A., Antoniou, K. M., & Aidinis, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687397 · Cited by 41
Combined Pulmonary Fibrosis and Emphysema
Nemoto, M., Koo, C. W., Scanlon, P. D., & Ryu, J. H. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.05.002 · Cited by 41
Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis
Naqvi, S. F., Lakhani, D. A., Sohail, A. H., Maurer, J., Sofka, S., Sarwari, A. R., & Hadi, Y. B. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-000969 · Cited by 32
Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells
Nikitopoulou, I., Fanidis, D., Ntatsoulis, K., Moulos, P., Mpekoulis, G., Evangelidou, M., Vassiliou, A. G., Dimakopoulou, V., Jahaj, E., Tsipilis, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810006 · Cited by 26
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
Sgalla, G., Magrì, T., Lerede, M., Comes, A., & Richeldi, L. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2765le · Cited by 27
Systemic sclerosis in the time of COVID-19
Hoffmann‐Vold, A., Distler, O., Bruni, C., Denton, C. P., de Vries-Bouwstra, J. K., Matucci‐Cerinic, M., Vonk, M. C., & Gabrielli, A. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00130-8 · Cited by 28
Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis
Ouyang, L., Gong, J., & Yu, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108145 · Cited by 23
Risk factors and severity of functional impairment in long COVID: a single-center experience in Croatia
Banić, M., Makek, M. J., Samaržija, M., Muršić, D., Boras, Z., Trkeš, V., Baričević, D., Koršić, M., Basara, L., Glunčić, T. J., et al. (2022) · Croatian Medical Journal · doi:10.3325/cmj.2022.27 · Cited by 27
Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study
Suppini, N., Firă-Mladinescu, O., Trăilă, D., Motofelea, A. C., Marc, M. S., Manolescu, D., Vaștag, E., Maganti, R. K., & Oancea, C. I. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13081190 · Cited by 29
Update in COVID-19 2020
Chotirmall, S. H., Leither, L. M., Çoruh, B., Chan, L., Joudi, A. M., Brown, S. M., Singer, B. D., & Seam, N. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202102-0415up · Cited by 20
How COVID-19 interacts with interstitial lung disease
Myall, K. J., Martinovic, J. L., & West, A. (2022) · Breathe · doi:10.1183/20734735.0158-2021 · Cited by 21
COVID-19: a new burden of respiratory disease among South African miners?
Naidoo, R. N., & Jeebhay, M. F. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000759 · Cited by 21
COVID-19 in complex common variable immunodeficiency patients affected by lung diseases
Milito, C., Soccodato, V., Auria, S., Pulvirenti, F., & Quinti, I. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000789 · Cited by 20
COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases
Fukihara, J., & Kondoh, Y. (2023) · Respiratory Investigation · doi:10.1016/j.resinv.2023.05.007 · Cited by 23
Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019
Neira, D. A. P., Watts, A., Seashore, J., Duarte, A. G., Nishi, S. P. E., Polychronopoulou, E., Kuo, Y., Baillargeon, J., & Sharma, G. (2021) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2021.0245 · Cited by 19
Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease
Choi, J. Y., Song, J. W., & Rhee, C. K. (2022) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2021.0141 · Cited by 18
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation
Papiris, S. A., Bouros, D. E., Markopoulou, K., Kolilekas, L., Papaioannou, A. Ι., Tzilas, V., Tzouvelekis, A., Fouka, E., Papakosta, D., Daniil, Z. D., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.03111-2020 · Cited by 18
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic
Favalli, E. G., Maioli, G., Biggioggero, M., & Caporali, R. F. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1908887 · Cited by 19
Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study
Çilli, A., Hanta, İ., Üzer, F., Çoşkun, F., Sevinç, C., Deniz, P. P., Parlak, M., Altunok, E., Tertemiz, K. C., & Ursavaş, A. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100900 · Cited by 17
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version
Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100948 · Cited by 18
The experience of people with idiopathic pulmonary fibrosis living through the COVID‐19 pandemic
Ryan, N., & Meskell, P. (2022) · Journal of Advanced Nursing · doi:10.1111/jan.15187 · Cited by 15
Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates
Wang, Y., Hao, Y., Hu, M., Wang, Y., & Yang, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109088 · Cited by 15
Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias
Álvarez, F. V., Martínez‐García, M. Á., Jiménez, D. G., Fariñas-Guerrero, F., de Lejarazu-Leonardo, R. O., López-Campos, J. L., Blanco‐Aparicio, M., Royo-Crespo, Í., García‐Ortega, A., García, A. T., et al. (2021) · Open Respiratory Archives · doi:10.1016/j.opresp.2021.100097 · Cited by 15
COVID-19 and Interstitial Lung Disease: Keep Them Separate
Podolanczuk, A. J., & Richeldi, L. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3918ed · Cited by 15
Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study
Martínez-Besteiro, E., Molina‐Molina, M., Gaeta, A. M., Aburto, M., Casanova, Á., Bobillo, J. R., Orozco, S., Rojo, R. P., Mayoral, R. G., Ballesteros, B. L.-M., et al. (2023) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2023.01.001 · Cited by 16
Mortality among Patients with COVID-19 and Different Interstitial Lung Disease Subtypes: A Multicenter Cohort Study
Zhao, J. L., Metra, B. M., George, G., Roman, J., Mallon, J., Sundaram, B., Li, M., & Summer, R. S. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202202-137rl · Cited by 14
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Candel, F. J., Barreiro, P., Salavert, M., Cabello, A., Fernández‐Ruiz, M., Pérez‐Segura, P., Román, J. S., Berenguer, J., Córdoba, R., Delgado, R. B., et al. (2023) · Viruses · doi:10.3390/v15071449 · Cited by 14
Recognizing risk factors associated with poor outcomes among patients with COVID-19
Rodriguez‐Miguelez, P., Heefner, A., & Carbone, S. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.01.006 · Cited by 13
Importance of Vaccination against SARS-CoV-2 in Patients with Interstitial Lung Disease Associated with Systemic Autoimmune Disease
Vázquez, N. M., García-Studer, A., Rojas-Gimenez, M., Romero-Barco, C. M., Arija, S. M., Mucientes, A., Velloso-Feijoó, M. L., Godoy‐Navarrete, F. J., Morales-Garrido, P., Redondo‐Rodríguez, R., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092437 · Cited by 12
Clinical Profile and Risk Factors for Severe COVID-19 in Hospitalized Patients from Rio de Janeiro, Brazil: Comparison between the First and Second Pandemic Waves
Leon, L. A. A., Coelho, W. L. D. C. N. P., Alves, A. D. R., Carneiro, V. C. D. S., Moreira, O. C., de Paula, V. S., Salvio, A. L., Duarte, L. A., Gutman, E. G., Fontes-Dantas, F. L., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072568 · Cited by 11
Pulmonary fibrosis and COVID-19
Kramer, D., Hilton, R., & Roman, J. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.07.006 · Cited by 14
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
Wallwork, R., Connolly, C. M., Shneyderman, M., McMahan, Z., Mecoli, C. A., Wigley, F., Hummers, L. K., Shah, A. A., & Paik, J. J. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00100-x · Cited by 11
Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service
Lee, K., Go, M. J., Choi, Y. Y., Kim, M.-K., Seong, J., Sung, H. K., Jeon, J., Jang, H., & Kim, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300306 · Cited by 12
COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes
Kahlmann, V., Manansala, M., Moor, C. C., Shahrara, S., Wijsenbeek, M. S., & Sweiss, N. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000812 · Cited by 10
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases
Chevalier, K., Génin, M., Petit-Jean, T., Avouac, J., Flipo, R., Georgin‐Lavialle, S., Mahou, S. E., Pertuiset, É., Pham, T., Servettaz, A., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1152587 · Cited by 10
Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung
Miura, Y., Ohkubo, H., Nakano, A., Bourke, J. E., & Kanazawa, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028613 · Cited by 9
Increased Levels of Galectin-3 in Critical COVID-19
Nikitopoulou, I., Vassiliou, A. G., Athanasiou, N., Jahaj, E., Akinosoglou, K., Dimopoulou, I., Orfanos, S. E., Dimakopoulou, V., Schinas, G., Tzouvelekis, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115833 · Cited by 9
Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version intégrale
Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.01.014 · Cited by 10
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
Granata, S., Carratù, P., Stallone, G., & Zaza, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.710543 · Cited by 8
Predictive model for the development of critical coronavirus disease 2019 and its risk factors among patients in Japan
Muto, Y., Awano, N., Inomata, M., Kuse, N., Tone, M., Takada, K., Fujimoto, K., Ueda, A., Hayashi, M., & Izumo, T. (2021) · Respiratory Investigation · doi:10.1016/j.resinv.2021.08.001 · Cited by 8
Malondialdehyde acetaldehyde adduction of surfactant protein D attenuates SARS‐CoV ‐2 spike protein binding and virus neutralization
Muralidharan, A., Bauer, C. D., Katafiasz, D. M., Pham, D., Oyewole, O. O., Morwitzer, M. J., Roy, E., Bailey, K. L., Reid, S. P., & Wyatt, T. A. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14974 · Cited by 9
The influence of prior use of inhaled corticosteroids on COVID-19 outcomes: A systematic review and meta-analysis
Chen, C., Wang, C., Chen, C.-Y., Wang, Y., Chen, K.-H., Lai, C., Wei, Y., & Fu, P.-K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295366 · Cited by 7
Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
Miyashita, K., Hozumi, H., Furuhashi, K., Nakatani, E., Inoue, Y., Yasui, H., Suzuki, Y., Karayama, M., Enomoto, N., Fujisawa, T., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02723-3 · Cited by 7
SECCION IX. Síndrome Post COVID-19: complicaciones tardías y rehabilitación
Saavedra, C. (2021) · Infectio · doi:10.22354/in.v25i4.979 · Cited by 9
The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea
Kim, S. H., Jhun, B. W., Jeong, B., Park, H. Y., Kim, H., Kwon, O. J., & Shin, S. H. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2022.37.e250 · Cited by 6
COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease
Panopoulos, S., Tzilas, V., Bournia, V.-K., Καραμανάκος, Α., Laskari, K., Bouros, D. E., Tektonidou, M. G., & Sfikakis, P. P. (2022) · Journal of Scleroderma and Related Disorders · doi:10.1177/23971983221143252 · Cited by 6
Mortality in patients with interstitial lung diseases hospitalized by severe or critical COVID-19
Pruneda, A. K. S., Barreto-Rodríguez, J. O., Selman, M., Juárez-Hernández, F., & Buendía-Roldán, I. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02697-w · Cited by 6
Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
Yamaya, T., Hagiwara, E., Baba, T., Iwasawa, T., & Ogura, T. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.04.006 · Cited by 6
Pulmonary Fibrosis in the Time of COVID-19
Buendía-Roldán, I., Valenzuela, C., & Selman, M. (2022) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2022.03.007 · Cited by 6
Impact of COVID-19 pneumonia on interstitial lung disease: semi-quantitative evaluation with computed tomography
Doğan, S., Güldiken, G. S., Alparslan, B., Barış, S. A., & Doğan, N. Ö. (2023) · European Radiology · doi:10.1007/s00330-023-09441-2 · Cited by 5
Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt?
Tikellis, G., Corte, T. J., Glaspole, I., Goh, N. S. L., Khor, Y. H., Wrobel, J. P., Symons, K., Fuhrmeister, L., Glenn, L. M., Chirayath, S., et al. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02396-6 · Cited by 5
COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy
Arai, T., Kurahara, Y., Moda, M., Kobayashi, T., Matsuda, Y., Kagawa, T., Sugawara, R., Tsuyuguchi, K., & Inoue, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12154940 · Cited by 6
A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019
Apostolo, D., Ferreira, L. L., Tizio, A. D., Ruaro, B., Patrucco, F., & Bellan, M. (2023) · Microorganisms · doi:10.3390/microorganisms11082038 · Cited by 5
Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease
Tikellis, G., Corte, T. J., Glaspole, I., Goh, N. S. L., Khor, Y. H., Wrobel, J. P., Symons, K., Fuhrmeister, L., Glenn, L. M., Chirayath, S., et al. (2024) · Chronic Respiratory Disease · doi:10.1177/14799731231226236 · Cited by 5
Impact of sarcopenia and obesity on mortality in older adults with SARS-CoV-2 infection: automated deep learning body composition analysis in the NAPKON-SUEP cohort
Schluessel, S., Mueller, B., Tausendfreund, O., Rippl, M., Deißler, L., Martini, S., Schmidmaier, R., Stoecklein, S., Ingrisch, M., Blaschke, S., et al. (2025) · Infection · doi:10.1007/s15010-025-02555-3 · Cited by 5
Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease
Sparks, J. A., Wallace, Z. S., & Robinson, P. C. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000812 · Cited by 5
The impact of COVID-19 on patients with preexisting interstitial lung disease
Udwadia, Z. F., Koul, P. A., & Dhooria, S. (2021) · Lung India · doi:10.4103/lungindia.lungindia_60_21 · Cited by 5
The occupational syndemics of miners in South Africa
Bulled, N. L., & Singer, M. C. (2024) · Discover Social Science and Health · doi:10.1007/s44155-024-00098-w · Cited by 4
Implementation of facemask sampling for the detection of infectious individuals with SARS-CoV-2 in high stakes clinical examinations – a feasibility study
Pan, D., Williams, C., Decker, J., Fletcher, E., Grolmusova, N., Bird, P. W., Martin, C. A., Nazareth, J., Rahman, L., O’Kelly, K., et al. (2024) · Future Healthcare Journal · doi:10.1016/j.fhj.2024.100175 · Cited by 4
Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report
Kai, Y., Matsuda, M., Suzuki, K., Kasamatsu, T., Kajita, A., Uno, K., & Muro, S. (2022) · Cureus · doi:10.7759/cureus.23411 · Cited by 4
Management of fibrotic hypersensitivity pneumonitis
Mullin, M. L. L., Churg, A., & Ryerson, C. J. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000904 · Cited by 4
Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease
Dutt, N., Shishir, S., Chauhan, N. K., Jalandra, R., Kuwal, A., Garg, P. K., Kumar, D., Vishwajeet, V., Chakraborti, A., Deokar, K. K., et al. (2022) · Cureus · doi:10.7759/cureus.27759 · Cited by 4
Synergistic Detrimental Effects of Cigarette Smoke, Alcohol, and SARS-CoV-2 in COPD Bronchial Epithelial Cells
Muralidharan, A., Bauer, C. D., Katafiasz, D. M., Strah, H. M., Siddique, A., Reid, S. P., Bailey, K. L., & Wyatt, T. A. (2023) · Pathogens · doi:10.3390/pathogens12030498 · Cited by 4
An explainable machine learning-driven proposal of pulmonary fibrosis biomarkers
Fanidis, D., Pezoulas, V. C., Fotiadis, D. I., & Aidinis, V. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.03.043 · Cited by 4
Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study
Strykowski, R. K., Patel, D. C., Neto, M. R., Hena, K., Gulati, M., Maier, L. A., & Patterson, K. C. (2022) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2022-001254 · Cited by 3
Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study
Pertzov, B., Shmueli, E., Zvi, H. B., Massarweh, A., Barkan, T., Ness, A., Shostak, Y., Freidkin, L., Shtraichman, O., & Kramer, M. R. (2022) · Respiratory Research · doi:10.1186/s12931-022-02155-x · Cited by 4
Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease
Kelly, C. A. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00256-9 · Cited by 3
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19
Scotto, R., Lanzardo, A., Buonomo, A. R., Pinchera, B., Cattaneo, L., Sardanelli, A., Mercinelli, S., Viceconte, G., Perrella, A., Esposito, V., et al. (2022) · Vaccines · doi:10.3390/vaccines10122043 · Cited by 4
Respiratory disorders and their association with clinical outcomes in COVID-19: a narrative review of current literature
Venkat, D., & Badr, M. S. (2023) · Annals of Palliative Medicine · doi:10.21037/apm-22-1427 · Cited by 4
Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data
Miao, M., Ma, Y.-H., Tan, J., Chen, R., & Men, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-78493-1 · Cited by 5
COVID-19 causing acute deterioration of interstitial lung disease: a case report
Hussain, M. R. K., Kulasekaran, N., Anand, A. M., & Danassegarane, P. R. (2021) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-021-00431-2 · Cited by 3
Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease
Mackintosh, J. A., Lipman, M. C. I., Lowe, D. M., & Renzoni, E. A. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00326-x · Cited by 3
Global burden, trends and projections analysis of interstitial lung disease and pulmonary sarcoidosis in elderly adults (aged 55+ Years) based on GBD 2021
Huang, Z., Xie, T., Tang, M., Chen, Z., Jia, D., Su, A., Jin, Z., Liang, T., & Wei, X. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347482 · Cited by 2
Management of chronic respiratory diseases during viral pandemics: A concise review of guidance and recommendations
Sharma, P., Mishra, M. K., Dua, R., Saini, L. K., & Sindhwani, G. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_974_21 · Cited by 2
SARS-CoV-2-Infektion und interstitielle Lungenerkrankungen – Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin
Behr, J., Berger, M. P., Blum, T. G., Bonella, F., Dinkel, J., Gläser, S., Hagmeyer, L., Kneidinger, N., Koschel, D., Prasse, A., et al. (2023) · Pneumologie · doi:10.1055/a-2007-9845 · Cited by 2
Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration
Williams, R., Hyams, C. J., Robertshaw, J., González, M. G., Szasz-Benczur, Z., White, P., Maskell, N. A., Finn, A. H. R., Barratt, S. L., Adegbite, D., et al. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107220 · Cited by 3

Authors: Esposito, A. J., Menon, A. A., Ghosh, A. J., Putman, R. K., Fredenburgh, L. E., El-Chemaly, S. Y., Goldberg, H. J., Baron, R. M., Hunninghake, G. M., & Doyle, T. J.
Affiliations: Brigham and Women's Hospital (US)
Brigham and Women’s Hospital, Boston, Massachusetts
Corresponding author: Doyle, Tracy J.
ORCID: Esposito, Anthony J.
Menon, Aravind A.
Ghosh, Auyon J.
Putman, Rachel K.
Fredenburgh, Laura E.
El-Chemaly, Souheil Y.
Goldberg, Hilary J.
Baron, Rebecca M.
Hunninghake, Gary M.
Doyle, Tracy J.
Venue: American Journal of Respiratory and Critical Care Medicine
Publisher: Oxford University Press (OUP)
Published: 2020-12-01
Volume: 202
Issue: 12
Pages: 1710-1713
ISSN: 1073-449X (ISSN-L)
1535-4970
DOI: 10.1164/rccm.202006-2441le
PMC: PMC7737588
OpenAlex: W3083942257
Cited by: 142
References: 9
Citations by year: 2026: 5 · 2025: 8 · 2024: 15 · 2023: 37 · 2022: 44 · 2021: 28 · 2020: 4
FWCI: 3.71
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1919 d)
Locations: American Journal of Respiratory and Critical Care Medicine (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (L30HL149048, R01HL111024, F32HL151132, K08HL140087, R01HL130974, R01HL135142)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords: interstitial lung disease, COVID-19 pandemic, mortality, SARS-CoV-2, comorbidities, risk factors
MeSH terms: COVID-19, SARS-CoV-2, Aged, Aged, 80 and over, Cause of Death, Female, Humans, Male, Middle Aged, Retrospective Studies, United States, Comorbidity, Survival Rate, Case-Control Studies, Lung Diseases, Interstitial, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased odds of death for patients with interstitial lung disease and covid-19: a case-control study

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks